Astera Labs, Inc. $ALAB Shares Acquired by Sumitomo Mitsui Trust Group Inc.

Key Points

• Sumitomo Mitsui Trust Group increased its stake in Astera Labs by 1,932.5% in Q4, adding 259,046 shares to hold 272,451 shares (about 0.16% of the company) valued at roughly $45.3 million.
• Company insiders have been net sellers, offloading a total of 701,042 shares worth about $88.0 million in the past 90 days, including CEO Jitendra Mohan and Director Manuel Alba.
• Analyst sentiment is largely positive with a consensus of “Moderate Buy” and an average price target of $199.44, while the company recently beat EPS estimates and reported revenue up 91.8% year‑over‑year.

Sumitomo Mitsui Trust Group Inc. raised its position in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 1,932.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 272,451 shares of the company's stock after acquiring an additional 259,046 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned approximately 0.16% of Astera Labs worth $45,325,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in ALAB. Vanguard Group Inc. raised its holdings in shares of Astera Labs by 14.1% during the third quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company's stock valued at $2,690,907,000 after acquiring an additional 1,693,918 shares during the last quarter. Amundi raised its holdings in shares of Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company's stock valued at $278,283,000 after acquiring an additional 1,319,643 shares during the last quarter. Rafferty Asset Management LLC acquired a new position in shares of Astera Labs during the third quarter valued at approximately $209,599,000. BNP Paribas Financial Markets raised its holdings in shares of Astera Labs by 577.3% during the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company's stock valued at $220,733,000 after acquiring an additional 960,899 shares during the last quarter. Finally, Voloridge Investment Management LLC acquired a new position in shares of Astera Labs during the third quarter valued at approximately $131,539,000. Institutional investors and hedge funds own 60.47% of the company's stock.

Insider Buying and Selling

In other news, CEO Jitendra Mohan sold 157,500 shares of the firm's stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $131.58, for a total transaction of $20,723,850.00. Following the completion of the transaction, the chief executive officer directly owned 4,531,732 shares in the company, valued at $596,285,296.56. This trade represents a 3.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Manuel Alba sold 183,000 shares of the firm's stock in a transaction on Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total value of $19,692,630.00. Following the transaction, the director owned 319,863 shares of the company's stock, valued at approximately $34,420,457.43. This represents a 36.39% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 701,042 shares of company stock valued at $88,018,149 in the last ninety days. Company insiders own 12.50% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on ALAB. Weiss Ratings cut Astera Labs from a "hold (c-)" rating to a "sell (d+)" rating in a report on Monday, February 23rd. Loop Capital started coverage on Astera Labs in a report on Thursday, March 5th. They set a "buy" rating and a $250.00 target price for the company. Citigroup started coverage on Astera Labs in a report on Thursday, April 2nd. They issued a "buy" rating and a $200.00 price target for the company. Royal Bank Of Canada started coverage on Astera Labs in a report on Wednesday, January 14th. They issued an "outperform" rating and a $225.00 price target for the company. Finally, Barclays set a $165.00 price target on Astera Labs in a report on Thursday, January 15th. Fifteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Astera Labs currently has a consensus rating of "Moderate Buy" and an average price target of $199.44.

Astera Labs Stock Performance

Shares of Astera Labs stock opened at $172.09 on Thursday. The firm has a market capitalization of $29.47 billion, a price-to-earnings ratio of 141.06, a PEG ratio of 3.36 and a beta of 1.78. Astera Labs, Inc. has a fifty-two week low of $52.56 and a fifty-two week high of $262.90. The stock has a 50 day moving average of $129.19 and a 200 day moving average of $154.42.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, topping the consensus estimate of $0.51 by $0.07. The company had revenue of $270.58 million during the quarter, compared to analyst estimates of $249.46 million. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The firm's revenue for the quarter was up 91.8% compared to the same quarter last year. During the same period in the prior year, the business posted $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.